NovaLign Intramedullary Fixation System (IFS) for the Treatment of Humeral Fractures

NCT00969839 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2009-09-18

No results posted yet for this study

Summary

This post-market clinical study is being done to evaluate the use of the NovaLign™ Intramedullary Fixation System in the treatment of humeral fractures.

Conditions

  • Fracture

Interventions

DEVICE

NovaLign Intramedullary Fixation System

Intramedullary fixation of broken humerus

Sponsors & Collaborators

  • NovaLign Orthopaedics, Inc

    lead INDUSTRY

Principal Investigators

  • B Crist, MD · University of Missouri-Columbia

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2011-03-31
Completion
2011-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00969839 on ClinicalTrials.gov